Journal
THERAPIE
Volume 75, Issue 5, Pages 503-506Publisher
ELSEVIER
DOI: 10.1016/j.therap.2019.07.006
Keywords
Teriflunomide; Multiple sclerosis; Adverse reaction; Bone pain; Safety